Biomaterials

Klean Kanteen Raises the Bar for Sustainability, Announces Use of Certified Recycled Stainless Steel

Retrieved on: 
Monday, August 2, 2021

Now, by using certified recycled steel instead of virgin steel, Klean Kanteen is extending the life of raw materials and reducing Klean Kanteens environmental impact.

Key Points: 
  • Now, by using certified recycled steel instead of virgin steel, Klean Kanteen is extending the life of raw materials and reducing Klean Kanteens environmental impact.
  • Klean Kanteen products made with certified recycled stainless steel will roll out in a phased launch online and in-store.
  • Starting in Spring 2022, Klean Kanteen will begin manufacturing its TKWide and Straw lines using certified recycled stainless steel.
  • By 2023, 95% of Klean Kanteen products will be made from certified recycled stainless steel.

Universal Stainless to Present at Jefferies 2021 Virtual Industrials Conference on August 3rd

Retrieved on: 
Wednesday, July 28, 2021

BRIDGEVILLE, Pa., July 28, 2021 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that Dennis M. Oates, Chairman, President and Chief Executive Officer, will present at the Jefferies 2021 Virtual Industrials Conference on Tuesday, August 3rd, from 10:30 to 10:55 a.m. (Eastern).

Key Points: 
  • BRIDGEVILLE, Pa., July 28, 2021 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that Dennis M. Oates, Chairman, President and Chief Executive Officer, will present at the Jefferies 2021 Virtual Industrials Conference on Tuesday, August 3rd, from 10:30 to 10:55 a.m. (Eastern).
  • The Company will post the slide presentation for this conference in the investor relations section of its website at www.univstainless.com .
  • Jefferies will host a live webcast of the Companys presentation, which can be accessed at https://wsw.com/webcast/jeff190/usap/1864845 and in the investor relations section of the Universal Stainless website.
  • About Universal Stainless & Alloy Products, Inc.
    Universal Stainless & Alloy Products, Inc., established in 1994 and headquartered in Bridgeville, PA, manufactures and markets semi-finished and finished specialty steels, including stainless steel, nickel alloys, tool steel and certain other alloyed steels.

Global 3D Printing Metals Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021

The "3D Printing Metals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "3D Printing Metals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. Market is Estimated at $299 Million, While China is Forecast to Grow at 28.8% CAGR
    The 3D Printing Metals market in the U.S. is estimated at US$299 Million in the year 2020.
  • In the global Stainless Steel segment, USA, Canada, Japan, China and Europe will drive the 25.3% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$729.9 Million by the year 2027.

NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery

Retrieved on: 
Thursday, July 22, 2021

SAN DIEGO, July 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of Modulus® ALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.

Key Points: 
  • SAN DIEGO, July 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the commercial launch of ModulusALIF, a 3D-printed porous titanium implant for anterior lumbar interbody fusion (ALIF), in targeted global regions.
  • Modulus ALIF is the latest addition to the NuVasive Advanced Materials Science (AMS) portfolio and provides implants and instrumentation designed for both supine ALIF and XALIFprocedures.
  • In addition, Modulus ALIF comes in a variety of sizes and lordotic options to accommodate varying patient anatomy.
  • Highlights of the Modulus ALIF technology include:
    Proprietary Modulus titanium design: Modulus is designed for enhanced osseointegration,1 biomechanical,1 and imaging properties.

Terasaki Institute for Biomedical Innovation and Tetratherix™ Form Collaboration

Retrieved on: 
Tuesday, July 20, 2021

LOS ANGELES, July 20, 2021 /PRNewswire/ -- The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with Tetratherix, a company which produces Tetramatrix, a synthetic injectable hydrogel currently being clinically tested in a variety of biomedical applications.

Key Points: 
  • LOS ANGELES, July 20, 2021 /PRNewswire/ -- The Terasaki Institute for Biomedical Innovation (TIBI) has formally signed a collaborative agreement with Tetratherix, a company which produces Tetramatrix, a synthetic injectable hydrogel currently being clinically tested in a variety of biomedical applications.
  • The unique and advantageous features of Tetramatrix offers the potential for further development into biocompatible, adhesive bioinks for deep tissue applications.
  • "This project will allow us to conduct world-class research in collaboration with TIBI to further expand our product pipeline in key therapeutic areas," said Ali Fathi, Tetratherix Founder and Director.
  • It is the hope that by optimizing the Tetramatrix bioinks, the TIBI researchers can help to translate them into viable biomedical applications.

Universal Stainless Announces Base Price Increase on Long Products

Retrieved on: 
Monday, July 19, 2021

BRIDGEVILLE, Pa., July 19, 2021 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today announced a base price increase of 3% to 10% on all long products.

Key Points: 
  • BRIDGEVILLE, Pa., July 19, 2021 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today announced a base price increase of 3% to 10% on all long products.
  • Given the current inflationary environment, this price adjustment is necessary to support our operations and ongoing reinvestments into our facilities to better serve our customers.
  • About Universal Stainless & Alloy Products, Inc.
    Universal Stainless & Alloy Products, Inc., established in 1994 and headquartered in Bridgeville, PA, manufactures and markets semi-finished and finished specialty steels, including stainless steel, nickel alloys, tool steel and certain other alloyed steels.
  • The Company's products are used in a variety of industries, including aerospace, power generation, oil and gas, and heavy equipment manufacturing.

Vivex Biologics, Inc. Launches VIA Mend™ Synthetic Bone Fillers

Retrieved on: 
Thursday, July 15, 2021

The innovative line of bone graft substitutes can be molded to fill bone defects and supports an environment for bone growth.

Key Points: 
  • The innovative line of bone graft substitutes can be molded to fill bone defects and supports an environment for bone growth.
  • The bone graft matrix is slowly resorbed and replaced by new bone tissue during the natural healing process.
  • "VIVEX isexcited toprovide a next generation synthetic, a bioactive option added to our broad biologics portfolio, delivering surgeon access to newoptionsthat aid inbone formation,"said MichelePablos, MBA, VP and GM of Ortho & Fusion Therapies at VIVEX.
  • "Our next generation VIA Mend Bioactive Strip sets us apart from the many synthetic competitors as it is the perfect trio of Carbonate Apatite bone mineral, highly purified Type I Collagen, and 45S5 Bioactive Glass."

PharmaCyte Biotech Announces Stability Test Results on Cells from Master Cell Bank

Retrieved on: 
Wednesday, July 14, 2021

This study is in addition to, and distinct from, the previously positive stability study test results of the CypCaps product after storage at -80C over various timepoints.

Key Points: 
  • This study is in addition to, and distinct from, the previously positive stability study test results of the CypCaps product after storage at -80C over various timepoints.
  • For this reason, the U.S. Food and Drug Administration requested that the stability of the MCB cells be analyzed.
  • PharmaCytes Chief Executive Officer, Kenneth L. Waggoner, said, We are pleased to have generated data on the viability and enzymatic activity of cells from our Master Cell Bank after 3 years storage.
  • PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box.

PharmaCyte Biotech Announces Results of Vote at Annual Meeting of Stockholders

Retrieved on: 
Thursday, July 8, 2021

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, today announced that all 4 proposals presented to the Companys stockholders for a vote at the 2021 Annual Meeting of Stockholders have passed.

Key Points: 
  • PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box, today announced that all 4 proposals presented to the Companys stockholders for a vote at the 2021 Annual Meeting of Stockholders have passed.
  • PharmaCytes 2021 Annual Meeting of Stockholders was held on June 16, 2021, and then adjourned until voting concluded on June 30, 2021.
  • The following proposals were approved at the Annual Meeting:
    Proposal One: To elect seven directors as nominated by the Board of Directors, each to serve a one-year term.
  • PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box.

Titanium in the Global Aerospace Industry will Witness Recovery in 2021 and Continued Growth to 2025 Following Pandemic Decline - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021

Q.5 What are the business risks and threats for titanium in the global aerospace industry?

Key Points: 
  • Q.5 What are the business risks and threats for titanium in the global aerospace industry?
  • Q.6 What are emerging trends for titanium in the global aerospace industry and the reasons behind them?
  • Q.7 What are some of the changing demands of customers for titanium in the global aerospace industry?
  • Q.10 What M&A activity has occurred in the last 5 years for titanium in the global aerospace industry?